Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Surging Prevalence Of Chronic Diseases
3.1.2. Health Practitioners Prefer Contrast Enhanced Ultrasound Imaging
3.1.3. Technological Advancements In Diagnosis
3.2. Key Restraints
3.2.1. Non-Uniformity Of Contrast Agents
3.2.2. Difficulty In Adoption In The Current Healthcare System

4. Key Analytics
4.1. Impact Of Covid-19 On Contrast Enhanced Ultrasound Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Value Chain Analysis
4.7. Key Buying Criteria
4.7.1. Cost Efficiency
4.7.2. Product Features
4.7.3. End-Use
4.8. Regulatory Framework

5. Market By Product
5.1. Equipment
5.2. Contrast Agent

6. Market By Type
6.1. Non-Targeted
6.2. Targeted

7. Market By End-User
7.1. Hospitals
7.2. Clinics
7.3. Ambulatory Diagnostic Centers

8. Geographical Analysis
8.1. Asia-Pacific
8.1.1. Market Estimates & Sizes
8.1.2. Key Growth Enablers
8.1.3. Key Challenges
8.1.4. Key Players
8.1.5. Country Analysis
8.1.5.1. China
8.1.5.2. Japan
8.1.5.3. India
8.1.5.4. South Korea
8.1.5.5. Indonesia
8.1.5.6. Singapore
8.1.5.7. Taiwan
8.1.5.8. Australia & New Zealand
8.1.5.9. Rest Of Asia-Pacific

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Mergers & Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.1.4. Business Expansions & Divestitures
9.2. Company Profiles
9.2.1. Bayer Ag
9.2.2. Bracco Diagnostic Inc
9.2.3. Daiichi Sankyo Company Limited
9.2.4. Ge Healthcare
9.2.5. Koninklijke Philips Nv
9.2.6. Lantheus Medical Imaging Inc
9.2.7. Nanopet Pharma Gmbh
9.2.8. Sanochemia Pharmazeutika Gmbh
9.2.9. Shenzhen Mindray Bio-Medical Electronics Co Ltd
9.2.10. Siemens Healthineers Ag
9.2.11. Taejoon Pharm
9.2.12. Trivitron Healthcare



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Value Chain Analysis
Figure 6: Key Buying Criteria
Figure 7: Asia-Pacific Contrast Enhanced Ultrasound Market, Growth Potential, By Product, In 2021
Figure 8: Asia-Pacific Contrast Enhanced Ultrasound Market, By Equipment, 2022-2030 (In $ Million)
Figure 9: Asia-Pacific Contrast Enhanced Ultrasound Market, By Contrast Agent, 2022-2030 (In $ Million)
Figure 10: Asia-Pacific Contrast Enhanced Ultrasound Market, Growth Potential, By Type, In 2021
Figure 11: Asia-Pacific Contrast Enhanced Ultrasound Market, By Non-Targeted, 2022-2030 (In $ Million)
Figure 12: Asia-Pacific Contrast Enhanced Ultrasound Market, By Targeted, 2022-2030 (In $ Million)
Figure 13: Asia-Pacific Contrast Enhanced Ultrasound Market, Growth Potential, By End-User, In 2021
Figure 14: Asia-Pacific Contrast Enhanced Ultrasound Market, By Hospitals, 2022-2030 (In $ Million)
Figure 15: Asia-Pacific Contrast Enhanced Ultrasound Market, By Clinics, 2022-2030 (In $ Million)
Figure 16: Asia-Pacific Contrast Enhanced Ultrasound Market, By Ambulatory Diagnostic Centers, 2022-2030 (In $ Million)
Figure 17: Asia-Pacific Contrast Enhanced Ultrasound Market, Country Outlook, 2021 & 2030 (In%)
Figure 18: China Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 19: Japan Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 20: India Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 21: South Korea Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 22: Indonesia Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 23: Singapore Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 24: Taiwan Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 25: Australia & New Zealand Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 26: Rest Of Asia-Pacific Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)

List of Tables

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING PREVALENCE OF CHRONIC DISEASES
3.1.2. HEALTH PRACTITIONERS PREFER CONTRAST ENHANCED ULTRASOUND IMAGING
3.1.3. TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSIS
3.2. KEY RESTRAINTS
3.2.1. NON-UNIFORMITY OF CONTRAST AGENTS
3.2.2. DIFFICULTY IN ADOPTION IN THE CURRENT HEALTHCARE SYSTEM
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON CONTRAST ENHANCED ULTRASOUND MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.7. KEY BUYING CRITERIA
4.7.1. COST EFFICIENCY
4.7.2. PRODUCT FEATURES
4.7.3. END-USE
4.8. REGULATORY FRAMEWORK
5. MARKET BY PRODUCT
5.1. EQUIPMENT
5.2. CONTRAST AGENT
6. MARKET BY TYPE
6.1. NON-TARGETED
6.2. TARGETED
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. CLINICS
7.3. AMBULATORY DIAGNOSTIC CENTERS
8. GEOGRAPHICAL ANALYSIS
8.1. ASIA-PACIFIC
8.1.1. MARKET ESTIMATES & SIZES
8.1.2. KEY GROWTH ENABLERS
8.1.3. KEY CHALLENGES
8.1.4. KEY PLAYERS
8.1.5. COUNTRY ANALYSIS
8.1.5.1. CHINA
8.1.5.2. JAPAN
8.1.5.3. INDIA
8.1.5.4. SOUTH KOREA
8.1.5.5. INDONESIA
8.1.5.6. SINGAPORE
8.1.5.7. TAIWAN
8.1.5.8. AUSTRALIA & NEW ZEALAND
8.1.5.9. REST OF ASIA-PACIFIC
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. BAYER AG
9.2.2. BRACCO DIAGNOSTIC INC
9.2.3. DAIICHI SANKYO COMPANY LIMITED
9.2.4. GE HEALTHCARE
9.2.5. KONINKLIJKE PHILIPS NV
9.2.6. LANTHEUS MEDICAL IMAGING INC
9.2.7. NANOPET PHARMA GMBH
9.2.8. SANOCHEMIA PHARMAZEUTIKA GMBH
9.2.9. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
9.2.10. SIEMENS HEALTHINEERS AG
9.2.11. TAEJOON PHARM
9.2.12. TRIVITRON HEALTHCARE

List of Tables
TABLE 1: ASIA-PACIFIC MARKET SNAPSHOT – CONTRAST ENHANCED ULTRASOUND
TABLE 2: EXAMPLES OF CURRENT CLINICAL ULTRASOUND CONTRAST AGENTS
TABLE 3: EXAMPLES OF EMERGING ULTRASOUND MICROBUBBLES-BASED TECHNIQUES
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET
TABLE 14: LIST OF MERGERS & ACQUISITIONS
TABLE 15: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 17: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

List of Figures
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
FIGURE 8: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY EQUIPMENT, 2022-2030 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY CONTRAST AGENT, 2022-2030 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
FIGURE 11: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY NON-TARGETED, 2022-2030 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY TARGETED, 2022-2030 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
FIGURE 14: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY CLINICS, 2022-2030 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY AMBULATORY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)
FIGURE 18: CHINA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 19: JAPAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 20: INDIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 21: SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 22: INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 23: SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 24: TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 25: AUSTRALIA & NEW ZEALAND CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 26: REST OF ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)